The Koebner Phenomenon in Bullous Pemphigoid
J Drugs Dermatol. 2024 Apr 1;23(4):e100-e101. doi: 10.36849/JDD.7796.NO ABSTRACTPMID:38564388 | DOI:10.36849/JDD.7796 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Payal Shah Akonam Olivia Anakwe Jenne Ingrassia Eamonn Maher Avrom Caplan Prince Adotama Source Type: research
Advancing Dermatology Education and Care in Rwanda: The Impact of a New Academic Partnership
J Drugs Dermatol. 2024 Apr 1;23(4):e120. doi: 10.36849/JDD.7833.NO ABSTRACTPMID:38564389 | DOI:10.36849/JDD.7833 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Ariel E Eber Sara Hogan Jean-Bosco Ndagijimana Natalie McCall Tania J Phillips Jeffrey S Dover Source Type: research
Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males
J Drugs Dermatol. 2024 Apr 1;23(4):e110-e112. doi: 10.36849/JDD.7844.NO ABSTRACTPMID:38564390 | DOI:10.36849/JDD.7844 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Nicole E Chin Andrea Hui Austin Source Type: research
Analysis of Utilization, Cost, and Prescription Trends of Common Immunosuppressive Medications Among Medicare Patients 2013 to 2019
J Drugs Dermatol. 2024 Apr 1;23(4):e113-e115. doi: 10.36849/JDD.7668.NO ABSTRACTPMID:38564391 | DOI:10.36849/JDD.7668 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Amar D Desai Nilesh Kodali Areebah S Ahmad Shari R Lipner Source Type: research
Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion
CONCLUSIONS: HASHA, a new NASHA-HD injectable with extra strength/firmness, was safe and effective for chin augmentation and correction of chin retrusion, with high aesthetic improvement and subject satisfaction throughout 12 months. J Drugs Dermatol. 2024;23(4):255-261. doi:10.36849/JDD.8145.PMID:38564392 | DOI:10.36849/JDD.8145 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Andreas Nikolis Shannon Humphrey Jason K Rivers Vince Bertucci Nowell Solish William McGillivray Kristy Bailey Nathan Rosen Andrei Metelitsa Annika Rugheimer Felipe Weinberg Inna Prygova Torun Bromee Source Type: research
Antihyperglycemic Medication to Combat Skin AGE-ing
J Drugs Dermatol. 2024 Apr 1;23(4):289-290. doi: 10.36849/JDD.0424.NO ABSTRACTPMID:38564393 | DOI:10.36849/JDD.0424 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Cleo Whiting Sara Abdel Azim Adam Friedman Source Type: research
A Silymarin Antioxidant Serum Improves Facial Acne Alone and as Part of a Treatment Regimen
CONCLUSION: Silymarin is shown in clinical testing to have significant benefits in reducing lipid peroxidation, oiliness, and PIH, and in improving key markers of skin aging. Additionally, the serum can be used alone or as an adjunctive treatment in acne therapy to further benefit aging, acne-prone skin. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8120.PMID:38564394 | DOI:10.36849/JDD.8120 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Source Type: research
Clinical Impacts of Omalizumab on the Psychiatric Comorbidities of Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
J Drugs Dermatol. 2024 Apr 1;23(4):e116-e117. doi: 10.36849/JDD.7919.NO ABSTRACTPMID:38564395 | DOI:10.36849/JDD.7919 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Marcus G Tan Adrian M J Bailey Brian Dorus Mark G Kirchhof Source Type: research
COVID-19 Protection Strategies: Lessons Learned About Epidermal Barrier Function and the Significance of Optimized Skin Care
J Drugs Dermatol. 2024 Apr 1;23(4):244-248. doi: 10.36849/JDD.7862.ABSTRACTInitially categorized as primarily a respiratory disease, COVID-19 can involve other organ systems and may have direct skin manifestations, including exanthems, morbilliform eruption, generalized urticaria, or pseudo-chilblains —commonly called “COVID Toes.” Frequent handwashing and prolonged wearing of face masks and shields in efforts to minimize transmission of SARS-CoV-2, the novel coronavirus that causes COVID, has given rise to indirect skin manifestations of COVID. “Maskne” and handwashing der...
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Leon Kircik James Q Del Rosso Source Type: research
Dermatologists' Perspectives on Biosimilars
Conclusion: Biosimilars are safe and effective for treating approved dermatological conditions and may lower patient costs compared to their reference products. Patients are not always offered biosimilar therapy as an option, which may be due to unfamiliarity among dermatologists. This survey suggests a need for more research and educational initiatives, such as modules and workshops that focus on biosimilar safety, efficacy, and interchangeability guidelines. J Drugs Dermatol. 2024;23(4):doi:10.36849/JDD.7755.PMID:38564397 | DOI:10.36849/JDD.7755 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Priscila Arellano Zameza Christina Kontzias Keith Flanders Peter Sonnenreich Steven R Feldman Source Type: research
Expression of IL-4 in Tumors: A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies
J Drugs Dermatol. 2024 Apr 1;23(4):e118-e119. doi: 10.36849/JDD.7941.NO ABSTRACTPMID:38564398 | DOI:10.36849/JDD.7941 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Nikolai Klebanov Carly Grant Jeffrey S Smith Lourdes M Perez-Chada Joseph F Merola Source Type: research
Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
CONCLUSIONS: Based on this SLR/NMA, topical triple-agent FDC gel was the most efficacious and safe treatment for moderate-to-severe acne. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8148.PMID:38564399 | DOI:10.36849/JDD.8148 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Julie C Harper Hilary Baldwin Saswata Paul Choudhury Deepti Rai Bikramaditya Ghosh Md Sohai Aman Abhra R Choudhury Sekhar Kumar Dutta Debalina Dey Subrata Bhattacharyya Tina Lin George Joseph Ankur A Dashputre Jerry K L Tan Source Type: research
A Practical Algorithm Integrating Skin Care With Nonenergy and Injectable Dermatologic Procedures to Improve Patient Outcomes and Satisfaction
CONCLUSION: Nonenergy and injectable procedures combined with skin care or topical treatments may improve outcomes and patient satisfaction. Topical antioxidants and free radical quenchers can combat photodamage and may offer a safe alternative to topical hydroquinone. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7918.PMID:38564400 | DOI:10.36849/JDD.7918 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Edward Lain Anneke Andriessen Valeria Barreto Campos Sabrina Guillen Fabi Lisa Ginn Ariel Haus Valerie M Harvey Jean-Fran çois Tremblay Source Type: research
Aesthetic Improvement With Topical Body Skin Treatment as a Complement to Cryolipolysis
Conclusion: This pilot study suggests that FTB may complement skin improvements seen post-NIBC.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7917.PMID:38564401 | DOI:10.36849/JDD.7917 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Craig Teller Harmony Saqr Elizabeth Makino Priscilla Huang Rahul Mehta Source Type: research
Human Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
Conclusion: Trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes. The use of combination topical formulations containing bakuchiol limits the comparison of bakuchiol’s efficacy with retinoids. Continued research with an improved trial design is needed.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7763.PMID:38564402 | DOI:10.36849/JDD.7763 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: James E Fanning Shayan A McGee Omer I Ibrahim Source Type: research
